Market	Type	Industry	Raised	Date
AIM	Introduction Re-admission	Pharmaceuticals & Biotech	nil	May 2009

CONTACTS

CEO: Michael Edelman

ADVISERS

Morgan Stanley
020-7425 8000	20 Cabot Square Canary Wharf London 4QW

Related Articles

• Palamon sells Australian Retail Decisions
• SkillSoft acquired by SSI
• Small but perfectly formed
  
• Palamon buys ADP
• Palamon acquires Associated Dental

People who read this article also read ...

• Clinton buys assets from Birthdays
• Eleco cements Milbury deal
• Hampson looks to raise funds
• Fast forward with interim managers
• Aussie insurer to sell
  UK operations